Makers Laboratories Ltd

₹ 155 -2.05%

12 Jun - close price

About

Incorporated in 1984, Makers Laboratories
Ltd is in the business of manufacturing and marketing of pharmaceuticals

Key Points

Business Overview:^[1]^[2]^[3]
The company markets 200+ generic formulations in India across major therapeutic segments like anti-malarial, antibiotics, anti-inflammatory, analgesics, and anti-diabetics, catering to dispensing doctors, nursing homes, and hospitals. It also undertakes job work for injectables (anti-malarial) for IPCA and procures products on a P2P basis from manufacturers in Himachal Pradesh and Uttarakhand's excise-free zones.

Website BSE

Market Cap ₹ 91.5 Cr.
Current Price ₹ 155
High / Low ₹ 230 / 122
Stock P/E
Book Value ₹ 95.0
Dividend Yield 0.00 %
ROCE -6.79 %
ROE -9.62 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company is almost debt free.

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -3.50% over past five years.
Company has a low return on equity of -11.4% over last 3 years.
Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	9.03	9.67	11.41	10.63	10.84	11.54	14.92	11.17	11.45	12.29	11.50	9.45	9.70
	10.05	11.19	12.00	12.48	11.02	13.32	15.63	12.28	11.59	12.56	11.66	10.01	10.92
Operating Profit	-1.02	-1.52	-0.59	-1.85	-0.18	-1.78	-0.71	-1.11	-0.14	-0.27	-0.16	-0.56	-1.22
OPM %	-11.30%	-15.72%	-5.17%	-17.40%	-1.66%	-15.42%	-4.76%	-9.94%	-1.22%	-2.20%	-1.39%	-5.93%	-12.58%
	0.08	0.13	0.69	0.14	0.18	0.19	0.69	0.12	0.15	0.14	10.19	0.57	0.03
Interest	0.40	0.37	0.33	0.40	0.28	0.35	0.41	0.42	0.46	0.39	0.33	0.13	0.09
Depreciation	0.47	0.48	0.60	0.66	0.66	0.67	0.68	0.68	0.68	0.71	0.71	0.73	0.69
Profit before tax	-1.81	-2.24	-0.83	-2.77	-0.94	-2.61	-1.11	-2.09	-1.13	-1.23	8.99	-0.85	-1.97
Tax %	-11.60%	1.79%	-13.25%	-7.58%	-12.77%	-5.75%	-10.81%	-7.18%	37.17%	-1.63%	10.57%	-9.41%	-28.93%
	-1.60	-2.27	-0.71	-2.57	-0.80	-2.46	-0.99	-1.95	-1.56	-1.22	8.03	-0.77	-1.40
EPS in Rs	-2.71	-3.85	-1.20	-4.36	-1.36	-4.17	-1.68	-3.30	-2.64	-2.07	13.61	-1.30	-2.37
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	68.37	64.91	61.41	58.13	55.95	46.60	51.31	44.34	52.34	42.46	48.85	42.94
	65.93	60.53	56.71	52.69	51.28	44.38	48.55	41.03	49.24	46.60	52.60	45.14
Operating Profit	2.44	4.38	4.70	5.44	4.67	2.22	2.76	3.31	3.10	-4.14	-3.75	-2.20
OPM %	3.57%	6.75%	7.65%	9.36%	8.35%	4.76%	5.38%	7.47%	5.92%	-9.75%	-7.68%	-5.12%
	0.21	0.94	0.41	1.24	1.50	2.56	0.18	0.41	0.80	1.14	1.14	10.92
Interest	0.49	0.39	0.36	0.27	0.36	0.26	0.70	1.60	1.68	1.38	1.63	0.94
Depreciation	0.97	1.53	1.25	1.08	1.57	1.50	1.99	4.20	1.91	2.40	2.71	2.85
Profit before tax	1.19	3.40	3.50	5.33	4.24	3.02	0.25	-2.08	0.31	-6.78	-6.95	4.93
Tax %	50.42%	30.88%	34.29%	30.77%	27.83%	18.87%	148.00%	-22.12%	45.16%	-6.05%	0.00%	5.88%
	0.60	2.35	2.31	3.70	3.06	2.45	-0.12	-1.62	0.17	-6.36	-6.95	4.64
EPS in Rs	1.02	3.98	3.92	6.27	5.19	4.15	-0.20	-2.75	0.29	-10.78	-11.78	7.86
Dividend Payout %	0.00%	20.94%	21.30%	13.30%	16.08%	20.08%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	-4%
5 Years:	-4%
3 Years:	-6%
TTM:	-12%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	26%

Stock Price CAGR
10 Years:	12%
5 Years:	30%
3 Years:	2%
1 Year:	23%

Return on Equity
10 Years:	-2%
5 Years:	-8%
3 Years:	-11%
Last Year:	-10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	4.92	4.92	4.92	4.92	4.92	4.92	4.92	4.92	4.92	5.90	5.90	5.90
Reserves	17.99	19.71	21.42	29.15	31.90	36.78	39.70	44.70	45.38	52.38	45.55	50.18
	2.12	0.80	0.18	1.43	1.29	6.38	13.05	15.99	19.40	11.20	15.37	1.75
	15.99	13.67	13.68	14.70	15.18	11.94	16.20	13.51	15.78	15.30	19.33	13.57
Total Liabilities	41.02	39.10	40.20	50.20	53.29	60.02	73.87	79.12	85.48	84.78	86.15	71.40
	11.94	11.47	10.39	17.30	16.62	18.10	32.89	30.59	29.94	40.45	39.88	29.37
CWIP	1.92	2.71	4.23	0.15	0.11	6.42	0.69	0.12	8.94	0.04	0.00	0.04
Investments	2.50	2.35	2.35	7.12	9.18	11.16	15.04	23.66	22.55	22.52	22.56	22.59
	24.66	22.57	23.23	25.63	27.38	24.34	25.25	24.75	24.05	21.77	23.71	19.40
Total Assets	41.02	39.10	40.20	50.20	53.29	60.02	73.87	79.12	85.48	84.78	86.15	71.40

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	1.30	1.32	3.52	5.53	0.21	5.39	4.23	0.67	6.80	-1.42	-3.06	-1.59
	-1.12	-1.00	-1.49	-2.96	-2.06	-8.31	-8.43	-2.65	-8.78	-3.55	-2.04	16.14
	-0.45	-0.38	-0.91	0.39	-1.09	3.92	2.91	1.37	1.77	4.94	5.12	-14.56
Net Cash Flow	-0.27	-0.06	1.12	2.96	-2.95	1.00	-1.29	-0.61	-0.21	-0.04	0.02	-0.01

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	66.89	66.58	85.65	75.73	73.20	39.32	53.71	59.19	37.31	64.73	49.09	44.71
Inventory Days	82.37	83.67	60.14	84.04	135.66	147.65	132.22	176.97	159.36	109.67	135.03	122.08
Days Payable	86.93	68.30	73.93	75.31	67.88	49.81	90.79	98.48	52.16	61.39	127.16	97.85
Cash Conversion Cycle	62.33	81.96	71.87	84.46	140.97	137.16	95.14	137.68	144.51	113.01	56.96	68.94
Working Capital Days	65.93	71.53	71.92	44.77	79.33	72.61	44.67	82.73	43.59	44.53	21.15	26.52
ROCE %	7.81%	13.08%	15.63%	15.54%	13.15%	7.63%	1.80%	-1.05%	3.02%	-7.77%	-7.84%	-6.79%

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	61.27%	61.28%	61.28%	61.28%	61.28%	61.28%	61.28%	61.28%	61.28%	61.28%	61.28%	61.28%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.39%	0.39%
	38.72%	38.73%	38.73%	38.72%	38.73%	38.73%	38.74%	38.73%	38.74%	38.73%	38.33%	38.34%
No. of Shareholders	4,753	4,839	4,621	4,483	4,402	4,283	4,179	4,176	4,090	4,008	4,031	4,135

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	58.37%	58.37%	58.37%	58.37%	58.37%	58.37%	61.28%	61.28%	61.28%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.39%
	41.63%	41.63%	41.63%	41.63%	41.63%	41.63%	38.72%	38.73%	38.34%
No. of Shareholders	5,001	4,386	4,085	3,933	3,914	4,667	4,483	4,176	4,135

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Makers Laboratories Ltd

Makers Laboratories Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings